Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform

EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell ...

2022-07-26 11:51 1837

Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong

Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI®, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and med...

2022-07-26 08:30 2370

Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development MONROE, Ohio, July 26, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced...

2022-07-26 03:35 2267

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

* Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissues * Rona licensed Sanofi's siRNA platform to enable discovery programs in expanded therapeutic areas including neuro and muscular diseases, for which Sanofi has an exclusive option to acquire neu...

2022-07-25 12:30 2216

Qiming's Portfolio Company InventisBio Lists on STAR Market

SHANGHAI, July 25, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange. The issue price isCNY 18...

2022-07-25 11:55 3461

Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

Early Detection Can Prevent 95% of Vision Loss Cases SEOUL, South Korea, July 25, 2022 /PRNewswire/ -- Diabetic retinopathy is the leading cause of blindness among working-age adults globally.1 With early detection and treatment, as much as 95 percent of vision loss cases can be prevented.2 Com...

2022-07-25 08:30 2383

Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

* Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the treatment of patients with Soft Tissue Sarcoma (STS) * The open label trial will evaluate efficacy and dose ranging in patients with advanced or metasta...

2022-07-25 07:09 2140

Merck Launches its Uptune Program in Asia for Collaborating with Startups

* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 SINGAPORE, July 22,...

2022-07-22 14:37 2143

Merck Launches its Uptune Program in Asia for Collaborating with Startups

Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises"

SHENZHEN, China, July 21, 2022 /PRNewswire/ -- On 12 July 2022, Menet held the award ceremony of the "Annual Top 100 China's Pharmaceutical Entreprises in 2021", in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the...

2022-07-21 22:32 2438

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) inMay 2022 – NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopha...

2022-07-21 21:25 2594

Mentice publishes the company's interim report for the period April - June 2022

GOTHENBURG, Sweden, July 21, 2022 /PRNewswire/ -- The acquisition of Ankyras is finalized and a large order in the quarter * The order book increased to 108.9 (67.9) MSEK and compared to 87.1 MSEK at the end of 2021. * We acquired all relevant assets relating to Ankyras from Galgo ...

2022-07-21 14:49 1418

BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION

SINGAPORE, July 21, 2022 /PRNewswire/ -- Baxter International, a global medtech leader, has announced the appointment ofSteven (Steve) Flynn to Senior Vice President and President Baxter Asia Pacific.

2022-07-21 09:58 3929

BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION

Telix Reports Second Quarter 2022 Financial Results

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended30 June 2022. All figures are in AUD$ unless otherwise stated. All fi...

2022-07-21 08:34 2261

First report from the world's most ambitious sequencing project

REYKJAVÍK, Iceland, July 20, 2022 /PRNewswire/ -- Scientists at deCODE genetics a subsidiary of Amgen together with collaborators fromDenmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature today.

2022-07-20 23:00 1285

First report from the world's most ambitious sequencing project

ABCAM PLC First Half Trading Update

CAMBRIDGE, England, July 20, 2022 /PRNewswire/ -- Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release it...

2022-07-20 21:50 2947

VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure

MELBOURNE, Australia, July 20, 2022 /PRNewswire/ -- Starpharma's broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2 Omicron variant in a stringent viral challenge model. VIRALEZE™ is a broad-spectrum barrier nasal spray, developed ...

2022-07-20 17:45 1569

BioWorld by Clarivate Explores the Concept of Extending Human Lifespan in New Report

Special report on aging investigates the latest science, key biological drivers and companies driving the development of potential "Fountain of Youth" candidate drugs LONDON, July 20, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted infor...

2022-07-20 15:00 1290

Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML

SAN FRANCISCO, ROCKVILLE, Md. and SUZHOU, China, July 20, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ...

2022-07-20 08:00 2327

U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older

* Recommendation follows U.S. FDA Emergency Use Authorization for the Novavax COVID-19 Vaccine, Adjuvanted as a two-dose primary series * FDA has determined that first vaccine lot has met all release specifications and is acceptable for use underEmergency Use Authorization * Novavax expects ...

2022-07-20 05:46 2167

Inteleos and Kenya Women and Children's Wellness Center Partner to Reduce Maternal and Fetal Mortality

Partnership aims to address United Nations Sustainable Development Goal 3.1 ROCKVILLE, Md., July 19, 2022 /PRNewswire/ -- Inteleos™, a non-profit global healthcare certification organization, and theKenya Women and Children's Wellness Center (KWCWC) signed a memorandum of understanding to reduce ...

2022-07-19 21:38 1322

1 ... 132 133 134135136 137 138 ... 382